GeistHaus
log in · sign up

The case for clinical trial abundance

slowboring.com

A supply-side reform agenda for one of our most urgent problems

6 pages link to this URL
Will all our drugs come from China?

Personal site for posts about my interests: the biotech industry, medicine, molecular biology, neuroscience, biorisk, science, consciousness, AI, innovation, decision making, philosophy, games, sci-fi, probability, and forecasting (among other things). I write to learn, mostly about biotech.

1 inbound link article en
Will all our drugs come from China?

Personal site for posts about my interests: the biotech industry, medicine, molecular biology, neuroscience, biorisk, science, consciousness, AI, innovation, decision making, philosophy, games, sci-fi, probability, and forecasting (among other things). I write to learn, mostly about biotech.

4 inbound links article en